Potential retinal disease treatments to be presented at ARVO

Preclinical results for two new compounds (Sirion) that may be used for the treatment of retinal diseases will be presented during the 2008 annual meeting of the Association for Research in Vision and Ophthalmology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.